A head-turning pegmatite intersection pushed the go button for a WA explorer as two hot spots continued to deliver the goods and a biotech’s blood test came up trumps.
FLASHPOINT - TRANSCRIPT
Tim - But first here's Matt Birney with the ASX Runners of the Week.
Tim - Thanks to Argonaut
Matt Birney - Thanks Tim.
Matt Birney - Well Forrestania Resources surged 173 per cent this week on the back of a 63-metre pegmatite drill intercept near Southern Cross.
Matt Birney - The market punted Forestania’s stock from 8.6 to 23 cents in the hope that intersection might have some lithium in it.
Matt Birney - Just north of Esperance, Metal Hawk got its talons into some high-grade rare earths assays, causing its stock to soar 158 per cent from 8.7 to 22.5 cents.
Matt Birney - And Western Yilgarn jumped from 7.5 to 17.5 cents - up 133 per cent - after unveiling some good-looking mineral targets near Chalice Mining’s famed Julimar nickel project.
Matt Birney - Notably, that project took Chalice from 10c to 10 bucks.
Matt Birney - And finally, cancer diagnostics company Inoviq nearly doubled following the tabling of some positive results relating to its breast cancer blood testing technology.
Matt Birney - Its share price hit 99 cents after closing out last week at just 50.5.
Matt Birney - And with around 190 biotech companies listed on the ASX these days, it's getting harder and harder to attract investor attention – a problem that Inoviq clearly overcame this week.